Drug Makers Reach $26 Billion Deal on Opioid Lawsuits
The money from the companies would be used by communities for addiction treatment, prevention services and other significant costs associated with the epidemic.
The money from the companies would be used by communities for addiction treatment, prevention services and other significant costs associated with the epidemic.